SUPRAVENTRICULAR TACHYCARDIA
Clinical trials for SUPRAVENTRICULAR TACHYCARDIA explained in plain language.
Never miss a new study
Get alerted when new SUPRAVENTRICULAR TACHYCARDIA trials appear
Sign up with your email to follow new studies for SUPRAVENTRICULAR TACHYCARDIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shorter heart drug course may be safe for infants
Disease control CompletedThis study looked at whether infants with supraventricular tachycardia (SVT) can safely stop heart medication after 4 months instead of the usual longer period. Researchers followed 107 infants aged 6 months or younger to see how many had a return of fast heart rate. The goal is …
Matched conditions: SUPRAVENTRICULAR TACHYCARDIA
Sponsor: Tampere University Hospital • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
Syringe showdown: which method stops racing heart faster?
Symptom relief CompletedThis study tested two methods of giving the drug adenosine to people with a rapid heart rhythm called supraventricular tachycardia (SVT). 131 adults in the emergency room received the drug either through one syringe or two syringes. The goal was to see which technique more effect…
Matched conditions: SUPRAVENTRICULAR TACHYCARDIA
Phase: PHASE4 • Sponsor: Hormozgan University of Medical Sciences • Aim: Symptom relief
Last updated May 11, 2026 20:48 UTC